• OPEN AN ACCOUNT
Indian Indices
Sensex
74,315.61 1,533.72
( 2.11%)
Global Indices
Nasdaq
51,633.03 -58.07
(-0.11%)
Dow Jones
7,740.63 -85.82
(-1.10%)
Hang Seng
64,657.00 -3,087.29
(-4.56%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.22 -0.47
(-0.50%)
EUR-INR
106.51 -0.49
(-0.46%)
GBP-INR
126.04 -0.53
(-0.42%)
JPY-INR
0.60 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4616629
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
44.25
14236.14
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0.29
 

Board of CRISIL approves merger of its Canadian subsidiaries
Jul 22,2026
The board of CRISIL at its meeting held on 21 July 2026 has approved amalgamation of Crisil Canada Inc. with Crisil PriceMetrix Inc., both wholly owned step-down subsidiaries of CRISIL.

Post amalgamation both the entities will cease to exist as separate entities and will form a single entity under the name “Crisil PriceMetrix Inc.”